Synthesis and pharmacological characterization of N-3-substituted willardiine derivatives: Role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLU(K5) kainate receptor antagonists




Dolman NP, More JCA, Alt A, Knauss JL, Pentikainen OT, Glasser CR, Bleakman D, Mayer ML, Collingridge GL, Jane DE

PublisherAMER CHEMICAL SOC

2007

Journal of Medicinal Chemistry

JOURNAL OF MEDICINAL CHEMISTRY

J MED CHEM

50

7

1558

1570

13

0022-2623

DOIhttps://doi.org/10.1021/jm061041u



Some N-3-substituted analogues of willardiine such as 11 and 13 are selective kainate receptor antagonists. In an attempt to improve the potency and selectivity for kainate receptors, a range of analogues of 11 and 13 were synthesized with 5-substituents on the uracil ring. An X-ray crystal structure of the 5-methyl analogue of 13 bound to GLU(K5) revealed that there was allowed volume around the 4- and 5-positions of the thiophene ring, and therefore the 4,5-dibromo and 5-phenyl (67) analogues were synthesized. Compound 67 (ACET) demonstrated low nanomolar antagonist potency on native and recombinant GLU(K5)-containing kainate receptors (K-B values of 7 +/- 1 and 5 +/- 1 nM for antagonism of recombinant human GLU(K5) and GLU(K5)/GLU(K2), respectively) but displayed IC50 values > 100 mu M for antagonism of GLU(A2), GLU(K6), or GLU(K6)/GLU(K2).



Last updated on 2024-26-11 at 21:25